Remote patient monitoring will boost CHF and GLP-1 care in 2025
The promise of remote patient monitoring is being reflected in increasing use of telemedicine, with enormous potential for everyday wellness, managing chronic conditions and promoting equity in healthcare.
Oren Nissim is CEO and co-founder of Brook Health, a healthcare management company that uses telehealth and artificial intelligence for home care. He sees big things for RPM in 2025, helping patients where they live in several key areas. We spoke to him about the trends he sees emerging in the coming year.
Q. You predict big things in congestive heart failure and remote patient monitoring this year. What do you see happening?
A. 2025 will transform the treatment of congestive heart failure as healthcare organizations recognize that traditional episodic care models cannot effectively manage the growing CHF population. Remote patient monitoring will evolve beyond simple vital sign tracking to become an intelligent early warning system that combines real-time physiological data with AI-powered pattern recognition to detect subtle signs of deterioration days before serious symptoms emerge.
The integration of AI-powered monitoring with human care teams will enable a new standard of proactive CHF management. Healthcare organizations will implement advanced triage protocols that automatically escalate patterns to clinical teams while providing patients with personalized guidance for daily self-management.
This combination will dramatically reduce pressure on emergency departments while improving patient outcomes.
The most significant impact will come from the ability to deliver specialized CHF expertise to each patient’s home. Remote patient monitoring platforms will enable cardiologists to extend their reach beyond geographic boundaries, provide expert guidance to local care teams, and ensure that every CHF patient has access to specialty-level care, regardless of location.
Q. Another area of RPM that you think will see significant activity is working with GLP-1 medications, the medications prescribed for controlling diabetes and losing weight. How do these two aspects of care go together?
A. 2025 will mark a crucial intersection between the GLP-1 revolution and remote patient monitoring, as healthcare organizations struggle to support unprecedented numbers of patients with these transformative medicines.
Combining GLP-1’s powerful effects on multiple chronic conditions with continuous remote monitoring will create opportunities for more accurate medication management and earlier intervention when problems arise.
Healthcare organizations will develop advanced remote patient monitoring protocols specifically designed for patients with GLP-1s, tracking not only weight and vital signs, but also medication adherence, side effects, and impact on multiple conditions, including diabetes, heart failure, and obesity.
This comprehensive monitoring allows healthcare teams to optimize dosing, manage side effects, and ensure patients receive maximum benefit from these expensive medications.
The integration of remote patient monitoring with GLP-1 therapy will provide unprecedented insights into the real-world impact of these drugs on chronic disease progression. These data will enable healthcare organizations to identify which patients are most likely to benefit from GLP-1s, predict potential complications, and develop more effective protocols for treating multiple chronic conditions simultaneously.
Q. Health equity is a big topic in healthcare today. Where do you see progress this year?
A. By 2025, remote care will see its greater potential to address long-standing healthcare inequities by bringing high-quality chronic disease management to underserved communities. Healthcare organizations will develop culturally competent remote care programs that combine RPM technology with human support to overcome language, health literacy, and trust barriers that have historically limited telehealth adoption in vulnerable populations.
The most successful programs will reach beyond traditional clinical monitoring and address social determinants of health, integrate community health workers into remote care teams, and connect patients to local resources for nutrition, transportation, and social support.
This comprehensive approach will demonstrate that technology, when properly combined with human touch, can bridge historic gaps in access and quality of care.
The impact on healthcare equity will be particularly evident in rural and urban underserved areas, where remote care will enable local primary care providers to manage complex chronic conditions with specialist-level support. By providing expert guidance and ongoing monitoring to communities that have historically lacked access to specialty care, these programs will begin to close long-standing disparities in chronic disease outcomes.
Follow Bill’s HIT coverage on LinkedIn: Bill Siwicki
Email him: bsiwicki@himss.org
Healthcare IT News is a HIMSS Media publication